Patrick Sven Plum

27PUBLICATIONS
60CO-AUTHORS
Planning and decision makingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyDevelopmental genetics (incl. sex determination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 03, 2025
Artificial neural networks as a prognostic tool using hyperspectral imaging on pretherapeutic histopathological specimens of esophageal adenocarcinoma.

Christel Teresa Trifone, Marianne Maktabi, Philipp Bischoff

|Sep 26, 2025
Long-term survival in peritoneal mesothelioma treated with 24 consecutive PIPACs.

Matthias Mehdorn, Boris Jansen-Winkeln, Philipp Rhode

|Aug 08, 2025
[Functional Outcome of Radiotherapy, Chemotherapy and Surgery in the Treatment of Rectal Cancer].

Philipp Rhode, Matthias Mehdorn, Undine Gabriele Lange

|Jul 09, 2025
Recurrence Patterns of Esophageal Adenocarcinoma in the Phase III ESOPEC Trial Comparing Perioperative Chemotherapy With Preoperative Chemoradiotherapy.

Jens Hoeppner, Claudia Schmoor, Thomas Brunner

|Apr 08, 2025
[Innovations in the Current Guideline on Gastric Carcinoma and Outlook for the Future].

Robert Nowotny, Philipp Rhode, Stefan Niebisch

|Jun 15, 2024
Integrative genomic analyses of European intrahepatic cholangiocarcinoma: Novel ROS1 fusion gene and PBX1 as prognostic marker.

Patrick S Plum, Timo Hess, Denis Bertrand

Pageof 5

Frequent Collaborators

9 joint publications

Seung-Hun Chon

4 joint publications

Robert Kleinert

4 joint publications

Axel Maximilian Hillmer

3 joint publications

Yue Zhao